Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Mitchochondrial replacement therapy: the IOM report and its aftermath

Nature Reviews Genetics volume 17, pages 189–190 (2016)Cite this article

Subjects

Glenn Cohen and Eli Adashi comment on recommendations and limitations of the Institute of Medicine (IOM) report on mitochondrial replacement therapies in light of recent legislative changes in the United States of America.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. National Academies of Sciences, Engineering, and Medicine. Mitochondrial replacement techniques: ethical, social, and policy considerations. (The National Academies Press, 2016).

  2. Herbert, M. & Turnbull, D. Mitochondrial replacement to prevent the transmission of mitochondrial DNA disease. EMBO Rep. 16, 539–540 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cohen, I. G., Savulescu, J. & Adashi, E. Y. Transatlantic lessons in regulation of mitochondrial replacement therapy. Science 348, 178–80 (2015).

    Article  CAS  PubMed  Google Scholar 

  4. The President's Council on Bioethics. Beyond therapy: biotechnology and the pursuit of happiness [online], (2003)

  5. Consolidated Appropriations Act, 2016. Sec. 749. Congress.gov [online], (2015).

  6. Cohen, C. I. The constitution and the rights not to procreate. Stanford Law Rev. 60, 1135–1196 (2008).

    Google Scholar 

  7. Foreign Assistance Act, 1973. Pub. L. No. 93-189, 87 stat. 714 (1973).

  8. Departments of Labor and Health, Education, and Welfare Appropriation Act, 1977. Pub. L. No. 94-439, 209, 90 Stat. 1418, 1434 (1976).

  9. The Balanced Budget Downpayment Act, I, Pub. L. No. 104-99, § 128, 110 Stat. 26, 34 (1996).

Download references

Acknowledgements

I.G.C. is supported by the Greenwall Foundation Faculty Scholars Program in Bioethics Award.

Author information

Authors and Affiliations

  1. Harvard Law School, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Griswold Hall 503, 1525 Massachusetts Avenue, Cambridge, 02138, Massachusetts, USA

    I. Glenn Cohen

  2. The Warren Alpert Medical School, Brown University, 101 Dudley Street, Providence, 02905, Rhode Island, USA

    Eli Y. Adashi

Authors
  1. I. Glenn Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eli Y. Adashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Glenn Cohen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cohen, I., Adashi, E. Mitchochondrial replacement therapy: the IOM report and its aftermath. Nat Rev Genet 17, 189–190 (2016). https://doi.org/10.1038/nrg.2016.21

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrg.2016.21

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing